“As a clinician, it is deeply concerning to see patients who are motivated and actively engaged in managing their diabetes be hindered by insulin affordability.”—Nykkia
People who need insulin cannot afford to live without it. However, most cannot financially afford the medication. As a clinician in diabetes management, I have listened to so many stories on how patients have had to ration insulin or omit doses to be able to afford the medication. It is very disheartening to hear how someone has to choose between purchasing insulin or groceries.
Insulin affordability is a matter of life and death, as insulin remains a critical, lifesaving medication for [some] people with diabetes. Recently, one of my patients experienced difficulty affording the insulin that has proven to work best with her insulin pump. While alternative formulary insulins are technically available, they have not provided the same level of glycemic target or consistency. As a result, she has struggled with maintaining stable blood glucose levels, creating both clinical concerns and emotional distress.
This situation has placed her in an unfair and dangerous position. She has to make a choice between financial strain and optimal health. The out-of-pocket cost of the recommended insulin is simply not sustainable, yet without it, her diabetes management becomes significantly less effective.
As a clinician, it is deeply concerning to see patients who are motivated and actively engaged in managing their diabetes be hindered by insulin affordability. I respectfully urge my colleagues in diabetes, advocates, and people with diabetes to strongly fight for insulin affordability!
“No parent should have to worry about whether they can afford the medication their child needs to stay alive.”—Tammi
My son was diagnosed with type 1 diabetes in 2024. Initially, his endocrinologist believed he had type 2 diabetes, but after additional testing, they called us back to let us know he actually had type 1 diabetes.
We immediately began diabetes education and started by closely monitoring his blood sugar levels. At first, monitoring alone was enough to help manage his condition. Eventually, however, his blood sugar became more difficult to control, and he was prescribed insulin.
The cost of insulin was a huge shock to me, and I was incredibly grateful to have health insurance at the time. Unfortunately, there came a period when I was unemployed and no longer had insurance, which meant the cost of insulin came directly out of my pocket. I was fortunate to qualify for a patient assistance program that covered his insulin for six months, but I often think about what would have happened if that program had not been available. No parent should have to worry about whether they can afford the medication their child needs to stay alive.
Today, my son is doing well. Like many teenagers, he sometimes gets frustrated with having to check his blood sugar and take insulin when his friends don't have to think about those things. Even so, he has remained committed to managing his diabetes, and I am incredibly proud of him. We have not experienced any diabetes-related emergencies or hospitalizations, and for that, I am truly grateful.
Our family's journey has shown me both the emotional and financial challenges that come with living with type 1 diabetes. It has also taught us resilience, the importance of education, and the value of having access to affordable healthcare and lifesaving medications.
“Patients should not have to choose between insulin to live and being able to afford their bills.”—Brandie
As a diabetes educator, the cost of insulin is a major barrier for my patients. When treating both type 1 diabetes and type 2 diabetes patients, having access to affordable insulin is essential for them. When insulin costs are elevated, patients with type 1 diabetes are choosing between staying alive or paying bills. For those patients living with Medicare who are already limited by income barriers, the cost capping in effect has made it possible for many of them to receive therapy that they need. Patients should not have to choose between insulin to live and being able to afford their bills.